Results 131 to 140 of about 5,550 (180)

Clonal Hematopoiesis of Indeterminate Potential (CHIP): A Model of Mutation-Driven Thromboinflammation. [PDF]

Cancers (Basel)
Malkots B, Stamatiou I, Panagiotopoulos E, Inglezou L, Sakka V, Vrachiolias G, Misidou C, Spanoudakis E, Kotsianidis I, Liapis K.   +9 more
europepmc   +1 more source

On the prenatal origins of the myeloproliferative neoplasms. [PDF]

EXCLI J
Langabeer SE.
europepmc   +1 more source

Toward new therapy end points in polycythemia vera: targeting clonal and inflammatory pathways. [PDF]

Blood Adv
Barbui T, Scandura JM.
europepmc   +1 more source

Polycythemia Vera with Incidental Large Aortic Aneurysm and Giant Cell Arteritis: Case Report. [PDF]

Clin Med Insights Case Rep
Obaid K, Sadek K, Al Jaber F, Altermanini M, Al-Mashdali AF, Yassin M, Alkhulaifi AM, Carr CS, Mohamed SF.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Absence of JAK2 V617F mutation in thalassemia intermedia patients

Molecular Biology Reports, 2008
JAK2 is a cytoplasmic tyrosine kinase that has a vital role in signal transduction from several hemopoietic growth factor receptors. The JAK2 V617F mutation has been implicated in a variety of diseases mainly related to myeloproliferative disorders including polycythemia Vera, essential thrombocythemia, and idiopathic Myelofibrosis but has not been ...
Ali Taher, Rami Mahfouz, Zaher Otrock
exaly   +3 more sources

Insights into JAK2-V617F mutation in CML

The Lancet Oncology, 2007
a case of JAK2-V617F mutation is CML.
Monica Bocchia, VANNUCCHI, ALESSANDRO MARIA, Alessandro Gozzetti, GUGLIELMELLI, PAOLA, POLI, GIADA, Rosaria Crupi, Marzia Defina, BOSI, ALBERTO, Lauria Francesco   +8 more
openaire   +5 more sources

The V617F JAK2 mutation and the myeloproliferative disorders

Hematological Oncology, 2005
AbstractThe discovery this year of a single mutation in the Janus Kinase (JAK)‐2 gene in a high percentage of cases of polycythaemia vera (PV), essential thrombocythaemia (ET) and myelofibrosis suggests that it maybe the underlying molecular mechanism for these disorders.
Percy, M.J., McMullin, Mary
openaire   +3 more sources